Close Menu

NEW YORK – Arna Genomics said over the weekend that it has raised $3.5 million in a Series A funding round led by Xploration Capital.

The Wilmington, Delaware-based startup will use the funds for clinical validation trials in Europe, the US, and the Commonwealth of Independent States for its Arna Breast diagnostic test, which detects nucleic acid fragments in a patient's plasma sample. The firm also plans to expand operations to the Indian and Chinese markets.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.